Trials / Terminated
TerminatedNCT03345953
Clinical Trial Assessing the Efficacy and Safety of BP1.4979 in Restless Legs Syndrome
Randomized Double Blind Parallel Groups Sequential, Placebo Controlled, Trial Assessing the Efficacy and Safety of BP1.4979 in Restless Legs Syndrome (RLS)
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 29 (actual)
- Sponsor
- Bioprojet · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a Group Sequential Test multicenter, randomized, double blind, placebo controlled phase II proof of concept trial with parallel groups to evaluate the efficacy and the safety of BP1.4979 15mg BID compared to placebo in RLS patients during 2 weeks double blind treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | BP 1.4979 | Double blind versus placebo |
| DRUG | Placebo | Double blind versus placebo |
Timeline
- Start date
- 2018-02-06
- Primary completion
- 2020-04-29
- Completion
- 2020-04-29
- First posted
- 2017-11-17
- Last updated
- 2020-07-30
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT03345953. Inclusion in this directory is not an endorsement.